Hope for the best, expect the worst? The interaction between side effect expectations and treatment outcomes of chemotherapy as part of a psychooncological panel study

Hope for the best, expect the worst? The interaction between side effect expectations and treatment outcomes of chemotherapy as part of a psychooncological panel study - HOPE

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028791

Enrollment

100

Registered

2022-04-19

Start date

2022-04-24

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C00-C97

Interventions

Group 1: Questionnaire at the beginning of chemotherapy or immunotherapy (T0), as well as two follow-up surveys after two (T1) and eight weeks (T2).

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Tumor patients undergoing outpatient treatment at the NCT Heidelberg; age of majority (= 18 years); sufficient German language skills; ability to give consent and availability of a written declaration of consent.

Exclusion criteria

Exclusion criteria: Severe cognitive, language, and/or physical impairment; severe psychiatric illness (e.g., addiction, schizophrenia).

Design outcomes

Primary

Measure	Time frame
Generic Rating Scale for previous Treatment Experiences, Treatment Expectations and Treatment Effects (GEEE); Herth Hope Index (HHI-D); sef-efficacy (Cancer Behavior Inventory (CBI-BD)); quality of life (Short-Form-Health Survey (SF-12)) Relevant measurement points: Baseline (treatment initiation), Follow-up1 (after 2 weeks), Follow-up2 (after 8 weeks).	—

Secondary

Measure	Time frame
Depression and anxiety (Patient Health Questionnaire-4 (PHQ-4)); adherence (single item) Relevant measurement points: Baseline (treatment initiation), Follow-up1 (after 2 weeks), Follow-up2 (after 8 weeks).	—

Countries

Germany

Contacts

Public ContactMiriam Grapp

Universitätsklinik Heidelberg, Psychoonkologische Ambulanz am Nationalen Centrum für Tumorerkrankungen (NCT)

miriam.grapp@med.uni-heidelberg.de+49 6221 564727

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026